ACKERMAN JOEL
SEC CIK 1220630 · EDGAR
BoughtSold
Most active insiders at DVA, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | BERKSHIRE HATHAWAY INC | 10% | — | $273.73M |
| 2 | BUFFETT WARREN E | 10% | — | $199.95M |
| 3 | Rodriguez Javier | CEO, Dir | — | $14.53M |
| 4 | ACKERMAN JOEL | CFO, Treasuer | — | $9.89M |
| 5 | Maughan David Paul | COO, DKC | — | $4.09M |
| 6 | HEARTY JAMES O | CCO | — | $3.29M |
| 7 | Waters Kathleen Alyce | Chief Legal, Pub. Affairs Off | — | $3.21M |
| 8 | Pullin Dennis W | Dir | — | — |
| 9 | Moore Gregory J. | Dir | — | — |
| 10 | Hollar Jason M. | Dir | — | — |
Transactions 41
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-05-11 16:05 | 2026-05-07 | DVA | DaVita | ACKERMAN JOEL | CFO, Treas | S - Sale | $192.10 | -51.5K | 132.4K | -28% | -$9.89M | |
| DM | 2026-03-17 | 2026-03-15 | DVA | DaVita | ACKERMAN JOEL | CFO, Treas | F - Tax | $150.72 | -42.8K | 223.4K | -16% | -$6.45M |
| D | 2026-03-17 | 2026-03-15 | DVA | DaVita | ACKERMAN JOEL | CFO, Treas | A - Grant | $0.00 | +5,706 | 226.7K | +3% | $0 |
| M | 2026-03-12 | 2026-03-10 | DVA | DaVita | ACKERMAN JOEL | CFO, Treas | A - Grant | $0.00 | +72.6K | 155.0K | +88% | $0 |
| D | 2026-02-09 | 2026-02-06 | DVA | DaVita | ACKERMAN JOEL | CFO, Treasuer | D - Sale to Iss | $149.22 | -32.2K | 153.5K | -17% | -$4.80M |
| D | 2026-02-09 | 2026-02-06 | DVA | DaVita | ACKERMAN JOEL | CFO, Treasuer | M - OptEx | $108.93 | +44.1K | 185.7K | +31% | +$4.80M |
| D | 2026-02-09 | 2026-02-06 | DVA | DaVita | ACKERMAN JOEL | CFO, Treasuer | F - Tax | $149.22 | -5,100 | 148.4K | -3% | -$761.0K |
| D | 2025-11-06 | 2025-10-30 | CSBR | CHAMPIONS ONCOLOGY, INC. | ACKERMAN JOEL | Dir | M - OptEx | $2.10 | +94.4K | 1.06M | +10% | +$198.3K |
| D | 2025-03-18 | 2025-03-15 | DVA | DaVita | ACKERMAN JOEL | CFO, Treasuer | A - Grant | $0.00 | +5,995 | 148.1K | +4% | $0 |
| DM | 2025-03-18 | 2025-03-15 | DVA | DaVita | ACKERMAN JOEL | CFO, Treasuer | F - Tax | $143.45 | -6,424 | 141.6K | -4% | -$921.5K |
| M | 2025-03-14 | 2025-03-12 | DVA | DaVita | ACKERMAN JOEL | CFO, Treasuer | A - Grant | $0.00 | +14.6K | 134.8K | +12% | $0 |
| DM | 2024-11-01 | 2024-10-31 | CSBR | CHAMPIONS ONCOLOGY, INC. | ACKERMAN JOEL | Dir | M - OptEx | $2.63 | +105.1K | 945.5K | +13% | +$276.3K |
| D | 2024-09-17 | 2024-09-16 | DVA | DaVita | ACKERMAN JOEL | CFO, Treasuer | M - OptEx | $75.95 | +79.0K | 185.7K | +74% | +$6.00M |
| D | 2024-09-17 | 2024-09-16 | DVA | DaVita | ACKERMAN JOEL | CFO, Treasuer | D - Sale to Iss | $163.56 | -36.7K | 149.1K | -20% | -$6.00M |
| D | 2024-09-17 | 2024-09-16 | DVA | DaVita | ACKERMAN JOEL | CFO, Treasuer | F - Tax | $163.56 | -21.6K | 127.5K | -14% | -$3.53M |
| M | 2024-08-29 | 2024-08-27+ | DVA | DaVita | ACKERMAN JOEL | CFO, Treasuer | S - Sale | $155.06 | -68.8K | 111.5K | -38% | -$10.66M |
| M | 2024-03-18 | 2024-03-14+ | DVA | DaVita | ACKERMAN JOEL | CFO, Treasuer | A - Grant | $0.00 | +26.8K | 183.6K | +17% | $0 |
| 2024-03-18 | 2024-03-15 | DVA | DaVita | ACKERMAN JOEL | CFO, Treasuer | F - Tax | $136.00 | -8,064 | 175.5K | -4% | -$1.10M | |
| D | 2024-03-08 | 2024-03-06 | DVA | DaVita | ACKERMAN JOEL | CFO, Treasuer | M - OptEx | $52.41 | +55.0K | 195.4K | +39% | +$2.88M |
| D | 2024-03-08 | 2024-03-06 | DVA | DaVita | ACKERMAN JOEL | CFO, Treasuer | D - Sale to Iss | $134.65 | -21.4K | 174.0K | -11% | -$2.88M |
| D | 2024-03-08 | 2024-03-06 | DVA | DaVita | ACKERMAN JOEL | CFO, Treasuer | F - Tax | $134.65 | -17.1K | 156.8K | -10% | -$2.31M |
| D | 2024-02-23 | 2024-02-21 | DVA | DaVita | ACKERMAN JOEL | CFO, Treasuer | F - Tax | $123.00 | -14.9K | 140.4K | -10% | -$1.84M |
| D | 2024-02-23 | 2024-02-21 | DVA | DaVita | ACKERMAN JOEL | CFO, Treasuer | M - OptEx | $52.41 | +55.0K | 178.7K | +44% | +$2.88M |
| D | 2024-02-23 | 2024-02-21 | DVA | DaVita | ACKERMAN JOEL | CFO, Treasuer | D - Sale to Iss | $123.00 | -23.4K | 155.3K | -13% | -$2.88M |
| D | 2024-01-05 | 2023-10-17 | CSBR | CHAMPIONS ONCOLOGY, INC. | ACKERMAN JOEL | Dir | M - OptEx | $2.10 | +114.6K | 857.0K | +15% | +$240.6K |
| M | 2023-05-17 | 2023-05-15 | DVA | DaVita | ACKERMAN JOEL | CFO, Treasuer | F - Tax | $96.86 | -20.5K | 136.6K | -13% | -$1.98M |
| D | 2023-05-12 | 2023-05-10 | DVA | DaVita | ACKERMAN JOEL | CFO, Treasuer | M - OptEx | $66.29 | +56.3K | 191.1K | +42% | +$3.73M |
| D | 2023-05-12 | 2023-05-10 | DVA | DaVita | ACKERMAN JOEL | CFO, Treasuer | D - Sale to Iss | $100.72 | -37.1K | 154.0K | -19% | -$3.73M |
| D | 2023-05-12 | 2023-05-10 | DVA | DaVita | ACKERMAN JOEL | CFO, Treasuer | F - Tax | $100.72 | -9,826 | 144.2K | -6% | -$989.7K |
| 2023-04-06 | 2023-04-04 | DVA | DaVita | ACKERMAN JOEL | CFO, Treasuer | A - Grant | $0.00 | +2,790 | 134.8K | +2% | $0 | |
| 2023-03-17 | 2023-03-15 | DVA | DaVita | ACKERMAN JOEL | CFO, Treasuer | A - Grant | $0.00 | +23.7K | 137.0K | +21% | $0 | |
| M | 2023-03-17 | 2023-03-15 | DVA | DaVita | ACKERMAN JOEL | CFO, Treasuer | F - Tax | $76.04 | -4,969 | 132.0K | -4% | -$377.8K |
| 2023-03-13 | 2023-03-09 | DVA | DaVita | ACKERMAN JOEL | CFO, Treasuer | A - Grant | $0.00 | +1,387 | 113.3K | +1% | $0 | |
| M | 2023-02-27 | 2023-02-23 | DVA | DaVita | ACKERMAN JOEL | CFO, Treasuer | A - Grant | $0.00 | +30.7K | 111.9K | +38% | $0 |
| D | 2022-10-20 | 2022-10-19 | CSBR | CHAMPIONS ONCOLOGY, INC. | ACKERMAN JOEL | Dir | M - OptEx | $3.21 | +16.7K | 1.46M | +1% | +$53.5K |
| M | 2022-05-17 | 2022-05-15 | DVA | DaVita | ACKERMAN JOEL | CFO, Treasuer | F - Tax | $100.05 | -34.0K | 88.8K | -28% | -$3.40M |
| M | 2022-04-21 | 2022-04-19 | DVA | DaVita | ACKERMAN JOEL | CFO, Treasuer | A - Grant | $0.00 | +46.8K | 86.8K | +117% | $0 |
| D | 2021-08-11 | 2021-08-09 | DVA | DaVita | ACKERMAN JOEL | CFO, Treasuer | M - OptEx | $68.89 | +145.2K | 180.7K | +409% | +$10.00M |
| D | 2021-08-11 | 2021-08-09 | DVA | DaVita | ACKERMAN JOEL | CFO, Treasuer | F - Tax | $133.17 | -37.2K | 68.3K | -35% | -$4.96M |
| D | 2021-08-11 | 2021-08-09 | DVA | DaVita | ACKERMAN JOEL | CFO, Treasuer | D - Sale to Iss | $133.17 | -75.1K | 105.6K | -42% | -$10.00M |
| 2021-08-06 | 2021-08-05 | DVA | DaVita | ACKERMAN JOEL | CFO, Treas | S - Sale | $131.36 | -37.8K | 35.5K | -52% | -$4.96M |
Purchase Sale Sale after option exercise All abbreviations